Made by McGill hosts a webcast series in which they discuss current societal topics with a panel of McGill experts. These hour-long conversations enrich the listeners’ understanding of an important topic, such as the impact of social media and the future of the economy. In its latest webcast, Made by McGill had the pleasure of featuring Jerry Pelletier, Ph.D., and Professor at the Goodman Cancer Institute (GCI), as one of the guests to discuss RNA therapies.
In the webcast, Professor Pelletier traces the history of RNA studies at McGill back from the 1960s, explaining the academic contribution to understanding and engineering this molecule that is today the root of an emerging biopharmaceutical sector.
''In the 2010s we saw the emergence of Moderna who got into the RNA biology space, built a very sophisticated pipeline and amassed enormous expertise around converting that molecule into a new medicine'', explains Pelletier. ''The reason why mRNA vaccines are so effective is that they are safer, more potent, and simpler to design than traditional vaccines.''
Jerry Pelletier also discussed the role of RNA therapies in enhancing immune therapy, thereby promoting our body’s ability to fight cancer.
Hear more about Jerry Pelletier’s explanations on how to harness the potential of RNA to change patients’ lives by listening to the whole webcast.